newdrugapprovals.org
The U.S. Food and Drug Administration approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF).
Nintedanib FDA approves Ofev to treat idiopathic pulmonary fibrosis 10/15/2014 The U.S. Food and Drug Administration today approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibr…